About the Journal
Aims and scope of journal
Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field.
Topics of particular interest include, but are not limited to, the following:
- Preclinical studies of new compounds, especially those that provide mechanistic insights
- Clinical trials and observations
- Reviews related to new drugs and current management of hematologic malignancies
- Novel observations related to new mutations, molecular pathways, and tumor genomics
Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.
The 2017 journal metrics* for Blood Cancer Journal are as follows:
2-year Impact Factor: 8.125
5-year Impact Factor: 6.122
Immediacy index: 1.241
Eigenfactor® score: 0.00766
Article influence score: 2.115
Rank: 20/222 Oncology
*2017 Journal Citation Reports® Science Edition (Clarivate Analytics, 2018)
45 days from submission to acceptance
1,225 Altmetric Mentions
Visit the Nature Research journals metrics page for a description of these metrics.
ISI Web of Science
The ISSN (online) number for Blood Cancer Journal is 2044-5385.